People: Koninklijke DSM NV (RDSMY.PK)
de Swaan, Tom
Dr. Tom de Swaan has served as Member of the Supervisory Board of Koninklijke DSM NV since March 29, 2006. He is currently retired. The last position he held was Member of the Managing Board and Chief Financial Officer/Chief Risk Officer ABN AMRO. Dr. de Swaan also served as Non-Executive Director of the Board of GlaxoSmithKline Plc. He is Chairman and Chief Executive Officer of Zurich Financial Services, member Supervisory Board of Van Lanschot Bankiers (chairman until 21 December 2015), chairman Board of Trustees of Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital and chairman Advisory Board Rotterdam School of Management. Dr. de Swaan is Chairman of the Company's Audit Committee and Member of Remuneration Committee. He graduated from University of Amsterdam with a degree in Economics.
|Total Annual Compensation, EUR||67,500|
|Restricted Stock Awards, EUR||--|
|Long-Term Incentive Plans, EUR||--|
|All Other, EUR||2,454|
|Fiscal Year Total, EUR||69,954|